# Antiarrhythmic drugs

Drug · id `cardio:antiarrhythmic-drugs` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Also called: Anti-Arrhythmia Agents; Antiarrhythmics; Antiarrhythmic agents

Browse, organ or system: Heart  
Browse, condition area: Heart rhythm problems  

## In plain language

Antiarrhythmic drugs are medicines used to treat or prevent heart rhythm problems (arrhythmias). MeSH says they are often sorted into four main groups by how they act on the heart. The US labels for amiodarone, flecainide, propafenone, sotalol, dofetilide and dronedarone call each an antiarrhythmic, and their pages are filed under this class. This is the class page.

## Technical summary

Class page. MeSH descriptor D000889 (Anti-Arrhythmia Agents) is an exact match. Its scope note names agents for treating or preventing cardiac arrhythmias and sorts them into four main mechanism groups: sodium channel, beta-adrenergic, repolarization and calcium channel. Two US amiodarone labels read (Pacerone tablets, ANDA075135; Nexterone injection, NDA022325) describe amiodarone as an antiarrhythmic and as a class III antiarrhythmic drug that has the electrophysiologic characteristics of all four Vaughan Williams classes, and RxClass lists the established pharmacologic class Antiarrhythmic on US drug labels for it; amiodarone is filed under this page on that evidence, and flecainide, propafenone, sotalol, dofetilide and dronedarone on the RxClass class Antiarrhythmic for each of them. Two of the four MeSH groups, beta-adrenergic and calcium channel blockade, have class pages of their own in this atlas; they are linked, not repeated. Statements are scoped to the labels read. No trial result and no dose is recorded.

## Connected pages

- Files under this front: Medicines (`cardio:front-medicines`)
- MeSH: agents for treating or preventing cardiac arrhythmias: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- A US amiodarone label lists it among the uses of an antiarrhythmic agent: Ventricular tachycardia (`cardio:ventricular-tachycardia`)
- MeSH names beta-adrenergic blockade as one of four mechanism groups: Beta-blockers (drug class) (`cardio:beta-blockers`)
- MeSH names calcium channel blockade as one of four mechanism groups: Calcium channel blockers (`cardio:calcium-channel-blockers`)
- Has subtype: Amiodarone (`cardio:amiodarone`)
- Has subtype: Dofetilide (`cardio:dofetilide`)
- Has subtype: Dronedarone (`cardio:dronedarone`)
- Has subtype: Flecainide (`cardio:flecainide`)
- Has subtype: Propafenone (`cardio:propafenone`)
- Has subtype: Sotalol (`cardio:sotalol`)

## Provenance

Content hash: 71dac4c4257565dfb749bd4ad0a66f5e954c16e813f2f7530c56943364ce8096
Last substantive edit: 2026-11-18
Evidence last checked: 2026-11-18
